Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide

Onima Chowdhury, Jennifer O’Sullivan, Nikolaos Barkas, Guanlin Wang, Gemma Buck, Angela Hamblin, Ayalew Tefferi, Haifa K. Al-Ali, Giovanni Barosi, Timothy Devos, Heinz Gisslinger, Qian Jiang, Jean Jacques Kiladjian, Ruben Mesa, Francesco Passamonti, Vincent Ribrag, Gary Schiller, Alessandro M. Vannucchi, Daobin Zhou, Mary Frances McMullinJianhua Zhong, Robert Peter Gale, Adam J. Mead*, John Catalano, William Stevenson, Günther Gastl, Werner Linkesch, Jan Van Droogenbroeck, Philippe Mineur, Vikas Gupta, Andrew Turner, Thomas Nevill, Jianyong Li, Zhixiang Shen, Ting Liu, Dominique Bordessoule, Shanti Natarajan-Amé, Christian Recher, Jean Loup Demory, Richard Schlenk, Martin Griesshammer, Mario Cazzola, Giuseppe Saglio, Giorgina Specchia, Alessandro Rambaldi, Fabrizio Pane, Sonja Zweegman, Peter te Boekhorst, Reinier Raymakers, Kudrat Abdulkadyrov, Manana Sokolova, Galina Salogub, Andrey Zaritskiy, Francisco Cervantes, Juan Carlos Hernández Boluda, Emilio Ojeda, Daniel Tesfa, Lars Nilsson, Mark Drummond, John Reilly, Claire Harrison, Dragana Milojkovic, Candido Rivera, Emmanuel Besa, H. Joachim Deeg, John Mascarenhas, Josef Prchal, Ramon Tiu, Moshe Talpaz, Jen Chin Wang, Raajit Rampal, Damiano Rondelli, Kelly McCaul, Randall Brown, Norio Komatsu, Kazuma Ohyashiki, Kiyoshi Ando, Hiroshi Kawabata, Katsuto Takenaka, Tomoko Hata, James Vardiman, for the RESUME trialists

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalLeukemia
DOIs
Publication statusAccepted/In press - 1 Jan 2020

Cite this